Production and manipulation of elevated temperatures in pig abdomen with a three-electrode capacitive heating device

The ability of a three-electrode capacitive heating device operating at 13.56 MHz to produce and effect spatial redistribution of hyperthermic temperatures is demonstrated through abdominal heating studies conducted with 80 kg female and 65 kg male pigs. Temperature-time profiles over the respective heating periods were obtained in anterior and posterior superficial tissue and in selected abdominal organs. At selected times during heating, spatial redistribution of elevated temperatures was effected through adjustment of power settings for one or more of the three electrodes, i.e. through manipulation of the specific absorption rate (SAR) in-vivo.     

Activation of CNS circuits producing a neurogenic cystitis: evidence for centrally induced peripheral inflammation

We present a model of neurogenic cystitis induced by viral infection of specific neuronal circuits of the rat CNS. Retrograde infection by pseudorabies virus (PRV) of neuronal populations neighboring those that innervate the bladder consistently led to a localized immune response in the CNS and bladder inflammation. Infection of bladder circuits themselves or of circuits distant from these rarely produced cystitis. Absence of virus in bladder and urine ruled out an infectious cystitis. Total denervation of the bladder, selective C-fiber deafferentation, or bladder sympathectomy prevented cystitis without affecting the CNS disease, indicating a neurogenic component to the inflammation. The integrity of central bladder-related circuits is necessary for the appearance of bladder inflammation, because only CNS lesions affecting bladder circuits, i.e., bilateral dorsolateral or ventrolateral funiculectomy, as well as bilateral lesions of Barrington's nucleus/locus coeruleus area, prevented bladder inflammation. The close proximity in the CNS of noninfected visceral circuits to infected somatic neurons would thus permit a bystander effect, leading to activation of the sensory and autonomic circuits innervating the bladder and resulting in a neurogenic inflammation localized to the bladder. The present study indicates that CNS dysfunction can bring about a peripheral inflammation.     

Structure–Activity Relationship Studies on (R)‐PFI‐2 Analogues as Inhibitors of Histone Lysine Methyltransferase SETD7

SETD7 is a histone H3K4 lysine methyltransferase involved in human gene regulation. Aberrant expression of SETD7 has been associated with various diseases, including cancer. Therefore, SETD7 is considered a good target for the development of new epigenetic drugs. To date, few selective small‐molecule inhibitors have been reported that target SETD7, the most potent being (R)‐PFI‐2. Herein we report structure–activity relationship studies on (R)‐PFI‐2 and its analogues. A library of 29 structural analogues of (R)‐PFI‐2 was synthesized and evaluated for inhibition of recombinantly expressed human SETD7. The key interactions were found to be a salt bridge and a hydrogen bond formed between (R)‐PFI‐2′s NH₂⁺ group and SETD7′s Asp256 and His252 residue, respectively.     

Towards chip prototyping: a model for droplet formation at both T and X-junctions in dripping regime

Segmented flows in both T and X-junction glass microchannels are investigated. The effective pressure domain of use of the microchips are compared for two chemical systems. After studying the flow patterns and current empirical equations proposed in the literature, a new empirical equation is validated for both T and X-junctions allowing the prediction of not only the domain of use of the microchip in terms of flow rates knowing the viscosities of the two phases but also the droplets diameter, volume, spacing, and specific interfacial area. Specific interfacial area could be optimized using the model within our specific microsystems, and a maximum of 10,000 m^?1 is determined. Ensuing the definition of the model, several insights in the way to optimize segmented flows for different purposes are discussed, i.e., for the production of monodisperse populations of droplets and mass transfer optimization.     

Dry Reforming of Methane with a Ni/Al2O3‐YSZ Catalyst: The Role of the Catalyst Preparation Protocol

Many studies of Ni based ceramic supporting reforming catalysts are found in the literature. A synthesis of the reported results shows that their efficiency and durability are significantly affected by their fabrication protocol. This research has been aimed at evaluating how the conditions of 1) the ceramic support preparation and 2) the Ni deposition, through an impregnation‐drying‐calcination‐reduction protocol, affect the catalytic activity and the catalyst deactivation over time during methane dry reforming. The catalyst support used in this study was obtained by the mixing and pressing of alumina and YSZ (Yttria Stabilized Zirconia) powders, then calcining the mixtures at high temperature to form pellets of limited porosity (specific surface of 1.5‐10 m²/g), without inducing change to the crystalline phases. The results show that the surface density of the nickel particles, the catalyst activity, and its life span are highly dependent upon the catalyst preparation protocol. The initial nitrate solution concentration, the duration of the impregnation and the specific surface of the ceramic support have, all of them, a considerable influence on the size range of the deposited nickel particles. The surface density, the amount and the size of the latter highly affect the catalytic activity. It has been also shown that an increase in the ratio CH₄/CO₂ is detrimental to the catalytic activity of the tested formulations; a small excess of methane is enough to initiate the deactivation process of the catalyst very quickly for all of the composition tested in this study. A phenomenological deactivation kinetics model has been built and optimized. Although there are differences in deactivation rates among the different formulations tested, the model shows that the deactivation rate is highly dependent upon the reaction rate constant and that zero‐ and first‐order kinetics give statistically the same prediction error; the latter is always lower or equal to the experimental error.     

Bioactive glasses as carriers for bioactive molecules and therapeutic drugs: a review

Bioactive glasses (BG) show great promise for bone tissue engineering based on their key properties, e.g., biocompatibility, biodegradability, osteoconductivity as well as osteogenic and angiogenic potential, which make them excellent candidates for bone tissue scaffolds and bone substitute materials. Recent work has shown that dissolution products of bioactive glasses have the potential to induce angiogenesis in addition to their known effect of influencing gene expression and promoting osteoblastic differentiation. One of the most interesting features of BG is their ability to bond both to soft and hard tissues, depending on their composition. To intensify the positive impact of BG for medical applications, there are considerable research efforts on using bioactive glass based platforms as carriers for the encapsulation, delivery and controlled release of bioactive molecules and therapeutic drugs. Different types of bioactive glasses have been considered in combination with different therapeutic drugs, hormones, growth factors and peptides. Using bioactive glasses as drug delivery system combines thus the effectiveness of therapeutic drugs (or bioactive/signaling molecules) with the intrinsic advantages of this inorganic biomaterial. Considering research carried out in the last 15?years, this review presents the different chemical compositions and morphologies of bioactive glasses used as carrier for bioactive molecules and therapeutic drugs and discusses the expanding potential of BG with drug delivery capability focusing in the field of bone tissue engineering.     

Temporal trends and controlling factors for polychlorinated biphenyls in the UK atmosphere (1991-2008)

Long-term air monitoring data sets are needed for persistent organic pollutants (POPs), to assess the effectiveness of source abatement measures and the factors controlling ambient levels. The Toxic Organic Micro-Pollutants (TOMPS) program in the United Kingdom started in 1991, generating a data set for polychlorinated biphenyls (PCBs). The history and volumes of production, usage, and subsequent restrictions on PCBs in the UK are well-characterized relative to many countries, providing a valuable case study on the effectiveness of controls and the factors influencing ambient levels and trends of these "model POPs". PCB air concentrations (congeners PCB 28, 52, 90/101, 118, 138, 153, and 180) from six rural and urban monitoring sites are presented. Most show a statistically significant decrease in PCBs levels over time, consistent with estimates of emissions, helping to validate emissions inventories. Times for a 50% decline in concentrations (sometimes called clearance rates) averaged 4.7 ± 1.6 years for all congeners at all sites. The trends at different sites and for different congeners were not statistically different from each other. Concentration differences between sites are correlated with local population density (i.e., the degree of urbanization), which supports approaches to modeling of primary emissions on the national and regional scale. The data set indicates that ambient levels and underlying trends of PCBs continue to reflect the controlling influence of diffuse primary sources from the ongoing stock of PCBs in urban environments. Production and use restrictions came into force in the UK over 40 years ago; trends since monitoring began in the early 1990s should be seen as part of a continuing decline in ambient levels since that time.